Published in Medical Letter on the CDC and FDA, February 7th, 2000
The demographic and geographic determinants of human T lymphotropic virus types I and II (HTLV-I and HTLV-II) are not well defined in the United States, noted E. L. Murphy and colleagues.
Murphy et al. measured antibodies to HTLV-I and HTLV-II in 1.7 million donors at five US blood centers during 1991-1995 ("Evidence among blood donors for a 30-year-old epidemic of human T lymphotropic virus type II infection in the United States," Journal of Infectious Diseases, 1999;180(6):1777-1783).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA